Show
Sort by
-
Splenic hematopoietic and stromal cells in cancer progression
-
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
-
Global alteration of CTCF binding in the cancer genome
-
Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary tract cancer : a Swedish population-based cohort study
-
PHF6loss drives IL7R oncogene addiction in TLX1 driven T-ALL
-
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastomas
-
Is a single driver gene mutation sufficient for monitoring early response in advanced colorectal cancer
-
Circulating tumor DNA detects early response to regorafenib in advanced colorectal cancer
-
A novel L-asparaginase with low L-glutaminase coactivity is highly efficacious against both T- and B-cell acute lymphoblastic leukemias in vivo
-
Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments